The prime ministers of France and the UK are set to obtain the AstraZeneca vaccine in opposition to coronavirus on Friday.
Each the UK’s Boris Johnson and France’s Jean Castex made the announcement on Thursday, the identical day that the EU’s medical regulatory physique deemed the Oxford-AstraZeneca shot “protected and efficient.”
Plenty of EU international locations, together with France, briefly halted administering the vaccine this week. They have been involved after blood clot issues have been reported in a small variety of vaccine recipients.
“There isn’t a motive for the French folks to show down the AstraZeneca COVID-19 vaccine,” authorities spokesman Gabriel Attal informed France’s RTL radio on Friday.
Why did international locations cease utilizing the AstraZeneca vaccine?
A complete of 13 EU member states briefly halted vaccinations with the British-Swedish shot after EU member states reported 30 circumstances of blood clot issues.
This included experiences of a uncommon and difficult-to-treat situation referred to as cerebral venous thrombosis (CVT).
The experiences sparked an investigation by the EU’s regulatory physique, the European Medicines Company (EMA)
AstraZeneca vaccine is protected, stress medical regulators
After the EMA declared the AstraZeneca COVID-19 vaccine protected to be used on Thursday, a number of European international locations together with Germany, started utilizing the shot once more.
It mentioned that it got here to a “clear scientific conclusion” that the advantages of the vaccine far outweigh the dangers.
Emer Cooke, the chief director of the EMA, mentioned the AstraZeneca vaccine is a “protected and efficient choice to guard residents from COVID-19.”
On the similar time, Cooke mentioned the EMA couldn’t “definitively rule out a hyperlink” between the vaccine and blood clots.
On Wednesday, the World Well being Group (WHO) mentioned that it was additionally finishing up an investigation into the blood clots in AstraZeneca vaccine recipients. Nevertheless it additionally advisable that international locations proceed to manage jabs as additionally they imagine the advantages outweigh the prices.
What sort of vaccine is AstraZeneca and the way does it work?
The vaccine was developed and produced by a staff from Oxford College and the British-Swedish pharmaceutical firm AstraZeneca. The analysis staff consists of scientists from the Jenner Institute and the Oxford Vaccine Group.
AstraZeneca’s vaccine is a vector virus vaccine. It makes use of a innocent chilly virus widespread to chimpanzees as a transport mechanism. The vaccine transports the floor protein of SARS-CoV-2 to human cells, the place it triggers an immune response in opposition to the coronavirus.
It’s notably helpful as a result of it doesn’t need to be saved at ultra-low temperatures, just like the BioNTech-Pfizer and Moderna vaccines. It additionally comes with a low price ticket.